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Introduction
Brucellosis is not only the most common zoonotic 
disease, but as a newly emerging disease, poses serious 
challenge to health policy makers worldwide [1]. 
Brucellosis is a major economic and public health issue 
with diverse geographical distributions worldwide [2].
The incidence of brucellosis is about 200 per 100,000 
population in some parts of the world [3]. This disease 
is still endemic in the Mediterranean, Middle East and 
Central Asian countries [4]. In some European and North 
American countries, the disease has been eradicated due 
to restrictions posed on international trade of animals 
and animal products [5]. Compared to Europe, North 
America and other developed areas of the world, the 
main burden of the disease is felt in the Mediterranean, 
South and Central America, Africa, Asia, the Indian 
subcontinent, Eastern Europe and the Middle East, 
especially Syria, Iraq, Egypt, Turkey and Iran [6, 7]. In 
addition, brucellosis care data often remains unknown 
due to diagnostic errors and lack of reporting and 
diversity of clinical cases [8].
There are significant differences in the incidence of this 
disease among countries. Iraq and Egypt have witnessed 
a 4 to 5-fold increase compared to other areas. This 
difference in incidence rates across regions reflects 
disparity in geographic, environmental, social, and 
economic factors and lifestyle [9].
Iran has the second highest prevalence of the disease 
worldwide [1]. However, the disease rate is not 
uniformly distributed throughout Iran, and this figure 
is higher in the western and northwestern provinces, so 
that this disease is endemic in some parts of Iran [10]. 
According to the latest statistics, the highest prevalence 
of the disease in Iran, ranging from 31 to 41 in 100,000 
people, belongs to the provinces of Lorestan, Markazi, 
East Azarbaijan and Kermanshah [11, 12].
Location and time are two important factors in the 
distribution of brucellosis in Iran. Hence, many studies 
have used GIS to investigate the distribution of this 
disease in Iran and elsewhere in the world [13, 14].
The GIS is utilized in two health spheres of epidemiology 
and health care [15, 16]. Therefore, since public health 
issues and disease spread are directly related to the 
geography of a region and always possess a spatial 
dimension, GIS can play a crucial role in managing and 
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planning public health issues and studying disease spread 
[17]. Therefore, as with other epidemics, gaining insights 
into the geographical pattern of brucellosis incidence 
is vital to interventions and disease management. The 
purpose of this study is to evaluate the incidence and 
geographical distribution of brucellosis using GIS in Iran.
Method
This is a descriptive-analytical cross-sectional study. 
The study includes spatial and climatic information as 
well as information on the prevalence rate of brucellosis 
in Iran. Initially, data on brucellosis from 2009 to 2015 
were collected and categorized from the Centers for 
Disease Control. The tables of brucellosis frequency and 
incidence were drawn for each year. The incidence rate 
for 100,000 people in the country was calculated. Then, 
GIS software was used to plot the map of the incidence 
and frequency of disease. The 2017 map of political 
divisions of Iran in vector format, developed by Iranian 
Mapping Organization, was used to develop a spatial 
database of the disease (To link descriptive information 
of the disease to the spatial data, a database is designed 
in GIS, and then verified by determining its geographical 
location using Google earth software).
Since data on incidence are obtained based on the 
findings of routine healthcare system, the difference in 
incidence that was observed in different provinces can 
be largely dependent on the sensitivity of the healthcare 
system to record and report cases in these provinces.
Laboratory diagnostic criteria for this disease are based on:
A) Separation of the agent (Brucella spp.) from clinical 
specimens in the culture site;
B) Brucella agglutination titers (STAT≥1/80) or 
seroagglutination test in one or more serum samples 
prepared after the onset of symptoms, or an at least 
four-fold increase in Brucella agglutination titers 2 
weeks after the initial test;
C) Testing 2-ME ≥ 1/40 (2-mercaptoethanol);
D) Coombs Wright test with 3 dilutions greater than 
Wright.
In order to make laboratory diagnostics at health centers, 
public and private laboratories across the country, directly 
on patient serum samples due to inadequate distribution 
and inadequate maintenance of Rose Bengal antigen, 
following clinical suspicion and physician testing. The 
Wright T test is also called standard agglutination test 
tube (STAT), and called agglutination test serum (SAT) 
will be done.
In order to make laboratory diagnostics at health centers, 
public and private laboratories across the country 
uniform, due to inadequate distribution and inadequate 
maintenance of Rose Bengal antigen, following clinical 
suspicion and physician request for testing, The Wright T 
test, also called standard agglutination test tube (STAT), 
and called agglutination test serum (SAT), will be done 
directly.
By preparing the geographic database of the disease, 
descriptive information such as incidence and frequency 
of disease was included in the GIS descriptive information 
table by Microsoft Excel software. Subsequently, spatial 
analysis was performed to map the distribution of disease 
incidence and frequency in Iran from 2009 to 2015.
With the information of each province available, the 
incidence and frequency of disease was developed for the 
whole country. In order to plot the map of interpolation, 
the inverse distance interpolation (IDW) method was 
used [18]. Interpolation map was plotted according to 
the total frequency and incidence of the disease. In order 
to plot the disease prediction map, we assumed that in 
regions with the highest incidence or frequency of the 
disease and the highest recurrence in a given period, 
the disease is more likely to spread. The fuzzy map 
of the disease over a specific period were multiplied 
by recurrence map of the disease in a given period by 
the Raster calculator, and finally the projection map of 
disease in future was plotted. In this map, the most likely 
areas of disease are shown in red.
Hotspot analysis
The Getis-Ord-Gi* statistic was used for appropriate 
spatial distribution of hot and cold spots. A disease is 
recognized as a hot spot when its figures and those of its 
surrounding conditions are fairly high. When Getis-Ord-
Gi* statistic is calculated to be 1, 2, 3, the confidence 
interval is estimated at 99%, 95%, 90%, respectively. 
The Getis-Ord-Gi* statistic is computed as follows [19]. 
Results
The results of the study revealed that brucellosis inci-
dence in males was significantly higher females (59% 
vs 41%). 
About 78% of patients lived in rural areas and 21% in 
urban areas. The incidence was 21% (1%) in the nomadic 
population, which may be due to the lack of reporting of 
the disease in the nomadic population.
A history of contact with livestock was reported in 78.7% 
of cases. 60% of patients had a history of consuming 
non-pasteurized dairy products and about 19% reported 
a history of contact with an infected person in the family 
as a source of contamination.
According to the results of study, the highest incidence 
of brucellosis was observed in the age group of 59-30 
(42.98%), and of all cases of brucellosis, 5.61% was 
related to children under 8 years of age and 11.22% to 
people aged above 60 (Tab. I). 
The results of the study exhibited that the highest incidence 
of brucellosis during 2009-2015 was in Lorestan, Hamedan 
and Kurdistan, Markazi, Kermanshah, East and West Azer-
baijan and North, South and Razavi Khorasan provinces, 
with 28 to 103 cases per 100,000 people (Tab. II).
The results showed that the trend of brucellosis in Iran from 
2009 to 2015 has been decreasing and increasing (Fig. 1).
The GIS maps show the incidence of brucellosis in 
different provinces during 2009-2015 (Fig. 2).
As displayed in Figure 3, the southern provinces (regions 
with higher temperatures, rainfall, vegetation and lower 
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livestock grazing) had the lowest incidence rates, and the 
northern, western, and northwestern provinces (regions 
with lower temperatures but rainfall, vegetation and 
higher livestock grazing) had the highest incidence of 
brucellosis during 2009-2015 period.
The incidence rate was projected for 2021 using ARC 
GIS software version 9.3, as shown in Figure 4. The 
prediction results for 2021 suggest that these provinces 
may witness a higher incidence rate in 2021, but this 
rising trend may be variable between provinces, with 
Lorestan, Hamedan and Kurdistan provinces facing a 
more steeped upward trend. Sistan and Baluchestan, 
Hormozgan and Khuzestan provinces may see slight 
variations in the incidence rate. In other words, tropical 
provinces are less likely to demonstrate any increasing 
or decreasing trends whereas cold and mountainous 
provinces (Lorestan, Hamedan, Kurdistan, East and 
West Azerbaijan, etc.) may experience a high incidence 
of brucellosis in 2021.
Overall, the results regarding brucellosis incidence rate 
in 2009–2015 and the prediction of its incidence rate in 
2021 suggest the absence of comprehensive measures 
to control the disease. With the current trend, we may 
observe a substantial increase in the incidence rate in 
most provinces of Iran.
Tab. I. Demographic information of patient with brucellosis in Iran 
from 2011 to 2015.
Frequency (%) Variable
28137 (41) Female Gender 
40612 (59) Male
53371 (78) Rural Living environment
14314 (21) Urban
459 (1) Nomadic

















7593 (11.22) 60 ≤
463 (0.7) Yes Complications of the disease
20103 (28.9) No
48925 (70.4) Indistinctive
Tab. II. Brucellosis incidence per 100,000 people in Iran during 2009-2015 period.
2015 2014 2013 2012 2011 2010 2009 Year ID
Province
44.24 44.55 41.35 35.05 21.40 41.39 43.85 East Azerbaijan 1
50.22 50.86 56.49 56.67 34.47 32.07 31.52 West Azerbaijan 2
19.69 19.83 20.13 14.55 14.90 16.41 16.96 Ardabil 3
16.53 16.68 19.21 13.27 10.47 8.17 9.42 Isfahan 4
5.24 5.34 6.47 3.42 3.19 1.45 0.00 Alborz 5
25.99 26.26 23.73 22.38 20.61 16.58 25.14 Ilam 6
4.99 5.09 3.06 2.94 2.71 1.00 2.06 Bushehr 7
2.74 2.77 2.55 2.01 1.52 2.62 1.58 Tehran 8
23.69 23.94 21.99 24.67 28.72 16.14 11.96 Chaharmahal and Bakhtiari 9
53.97 54.61 33.07 23.21 29.26 36.53 21.20 South Khorasan 10
39.48 40.05 42.23 35.24 32.65 30.75 30.09 Razavi Khorasan 11
44.44 44.94 39.08 29.16 23.73 15.54 16.35 North Khorasan 12
6.60 6.69 9.42 7.33 7.35 10.19 15.64 Khuzestan 13
58.32 58.93 43.01 30.99 27.95 22.79 26.36 Zanjan 14
31.05 31.57 33.79 19.50 18.54 15.57 24.27 Semnan 15
3.51 3.60 6.09 4.31 6.08 7.54 4.47 Sistan and Baluchestan 16
24.36 24.60 24.87 28.05 20.54 14.75 18.75 Fars 17
35.84 36.19 29.53 26.52 26.04 16.74 18.45 Qazvin 18
7.45 7.58 11.90 6.31 6.86 6.64 3.61 Qom 19
103.19 103.94 64.46 50.66 35.88 24.78 28.25 Kurdistan 20
16.33 16.57 19.17 15.96 14.32 16.60 19.89 Kerman 21
62.77 62.99 53.92 39.10 39.74 37.44 43.85 Kermanshah 22
27.17 27.60 12.92 10.16 9.26 9.04 17.90 Kohgiluyeh and Boyer-Ahmad 23
27.59 28.06 32.08 19.08 11.14 16.28 16.77 Golestan 24
2.36 2.37 2.63 3.04 2.66 2.84 1.80 Gilan 25
96.86 97.67 71.54 65.48 48.18 37.86 48.02 Lorestan 26
11.19 11.28 16.69 18.23 14.15 14.85 12.68 Mazandaran 27
34.69 35.03 41.33 51.47 42.36 37.64 46.50 Markazi 28
1.05 1.07 1.71 1.37 1.08 2.66 3.32 Hormozgan 29
93.65 94.12 84.30 64.71 47.50 37.55 32.78 Hamedan 30
15.24 15.56 26.86 13.95 15.08 12.30 13.76 Yazd 31
25.6 25.94 24.83 21.11 16.96 16.52 17.61 Total country ---
M. REZA SHIRZADI ET AL.
E638
Fig. 1. Trend of Brucellosis in Iran during 2009-2015.
Fig. 2A. The incidence of brucellosis from 2009 to 2015.
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Fig. 2B. The incidence of brucellosis in 100,000 people over 2009-2015 period in each province.
Fig. 3. Average incidence rate of brucellosis in Iran during 2009-2015.
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According to the results of hot spot analysis in Figure 
5, Kurdistan, Lorestan, Ilam, Zanjan and Kermanshah 
provinces may be among the hot spots in terms of 
incidence rate in 2021. The incidence rate of this disease 
in 2009-2015 period as well as the results of the hot spot 
analysis reveal that Lorestan and Kurdistan provinces 
face a grim prospect compared to other provinces and 
the incidence rate is expected to grow exponentially in 
future with the current increasing trend. 
Discussion
The importance of brucellosis is not due to health-
related complications of this disease but rather grave 
economic challenges posed by this disease, especially in 
developing countries [20, 21]. Iran is an endemic area for 
brucellosis and the incidence of this disease represents a 
serious national public health issue [21].
There are substantial variations in the frequency of 
Figure 4. Prediction of brucellosis incidence rate in 100,000 people in Iran in 2021.
Fig. 5. The predicted hot and cold spots for the incidence rate of brucellosis in Iran in 2021.
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brucellosis in different regions of Iran. The incidence 
varies from 98 to 130 cases per 100,000 people, with 
the southern regions of Iran reporting the lowest rate of 
infection [22]. The highest incidence rate in Iran, 130 per 
100 000 population, has been reported from Hamedan 
province in the west of the country [23].
According to the results of our study, the highest incidence 
of brucellosis during 2009-2015 was in Lorestan, 
Hamedan and Kurdistan, Markazi, Kermanshah, East and 
West Azerbaijan and North Khorasan, South Khorasan 
and Razavi Khorasan provinces. The results illustrate 
that the incidence of brucellosis in Iran dropped from 
2009 to 2011 but it assumed an increasing trend from 
2011 to 2014. Based on the results of modeling in Iran, 
Hamedan, Lorestan, West Kurdistan and East Azerbaijan 
provinces with 100%, 99.3%, 98.66%, 98.2% and 
97.1% of their area, respectively, are at a higher risk of 
brucellosis breakout in the coming years. 
Comparing the incidence of brucellosis in Iran to other 
countries shows its significantly higher incidence rate in 
Iran compared to developed countries such as the US 
and most European countries [24, 25]. The incidence 
rate in Iran closely resembles to eastern Mediterranean 
countries such as Saudi Arabia. Saudi Arabia [26], the 
United Arab Emirates [27], Turkey and Iraq [28].
Given that this disease is endemic in the Middle East 
region, its uneven distribution in different countries 
can be attributed to the low socioeconomic status and 
underdevelopment in the agricultural and livestock 
industry [7].
The results of this study reflect a rise in the incidence of 
brucellosis in Iran from 2011 to 2014 and a decline in 
2015 compared to 2014. This rising trend may be due to 
improved statistical system and data recording in Disease 
Registration System of Iran over the years and its decline 
in 2015 could be attributed to enhanced livestock health 
and vaccination [29]. The study of Zhang et al. (2014) in 
China showed that the total incidence of brucellosis in 
humans was 0.92 per 100,000 people in 2004, increasing 
to 2.6 per 100,000 people in 2010 [30]. In Turkey, the 
incidence rose to more than 25.6 [31]. 
According to the World Health Organization’s report, 
the prevalence of brucellosis varies widely (from 0.01 
to 200 per 100,000 populations), so that it is in the 
Native American regions, 1 in 100,000, in the UK, 0.3 
in 1 million. Germany is 0.03 per 100,000 and in rural 
Greece 0.3 per 100,000 [32-36].
According to a study (2003), the average incidence of 
brucellosis in the Iranian population was 21 per 100,000, 
however the rate varied between 1.5 and 107.5 per 
100,000 in different regions of the country [20].
In a systematic meta-analysis and review study conducted 
by Mirnejad et al. on the incidence of brucellosis over an 
18-year period, from 1996 to 2014, across the country, 
results from 34 articles showed tha the incidence of 
brucellosis was varied in different provinces, with the 
lowest reported incidence from Qom at 7 per 100,000 
and the highest incidence from Kermanshah province 
with 276.42 per 100,000 (38).
Thus, the growing incidence of the disease in the 
community is a wake-up call that this disease is turning 
into a public health problem in the community, which can 
inflict economic consequences to the community [37]. 
According to the results of our study, the highest 
incidence during 2006-2015 was in Lorestan, Hamedan 
and Kurdistan, Markazi, Kermanshah, East and West 
Azerbaijan and North Khorasan, South Khorasan and 
Razavi Khorasan provinces. The findings of the present 
study are aligned with those reported by other Iranian 
researchers [12, 13]. In the western provinces of Iran, 
due to proximity to the Zagros Mountains and the 
presence of dense oak forests and fertile soil, the main 
economic activities of the people are agriculture and 
animal husbandry. Also, due to the commute of nomadic 
tribes, these areas have a higher incidence of brucellosis 
than other parts of Iran [13, 38]. 
Based on the results of our study, the western provinces 
of the Iran including Hamedan, Lorestan, Kurdistan 
and West and East Azerbaijan may be high brucellosis 
risk areas in the coming years. High incidence rates in 
these provinces have been reported in other studies as 
well [12, 39]. 
Environmental or geographical factors, low and 
medium altitudes, humidity and vegetation, and climatic 
conditions in the west and northwest of the country have 
provided a fertile ground for the survival and spread of 
the disease. Therefore, the impact of geographical factors 
on the incidence of zoonotic diseases is undeniable [40].
Underdevelopment or absence of traditional health 
infrastructure and traditional lifestyle, low education 
and lower socioeconomic status in the western and 
northwestern parts of Iran can also be major factors in 
the transmission of this disease in these areas, which 
can turn them into high risk areas in the future [11, 37].
Evaluation and controlling the disease by identifying 
the center of the disease and assessing the incidence and 
prevalence of the disease at specific times and health-
quarantine measures could lead to adopting appropriate 
plans for disease control and prevention.
Conclusion
In general, the results suggest significant variations in 
the distribution of brucellosis incidence in Iran in the 
present and future. In the western and northwestern 
provinces of Iran, this disease can pose a major health 
issue, giving rise to a plethora of problems for people 
living in these areas. This calls for greater attention 
of health decision makers to the high risk areas of the 
country in the coming years to control the incidence of 
diseases in these areas by developing appropriate health 
plans and interventions. Providing policy and selection 
of appropriate operational methods using the facilities 
of the national health networks for the prevention and 
control of brucellosis based on disease diagnosis, early 
diagnosis, appropriate treatment, increasing awareness 
of the ways of transmission and prevention of the disease 
and coordination between different parts of the relevant 
organizations in a way that throughout the country is 
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accessible and is practiced uniformly can be used as a 
practical target to combat this disease.
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